Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPI-1005 in Meniere's Disease
NCT03325790Phase 2Completed
- Sponsor
- Sound Pharmaceuticals
- Start
- Sep 2017
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ebselen in Meniere's disease (MD), sponsored by Sound Pharmaceuticals. Started Sep 2017; status: completed.
02
Drugs
ebselen
03
Conditions
Meniere's disease (MD)
Beyond the preview
Go deeper on NCT03325790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03325790.